Sirolimus Tablets

Sirolimus Tablets
SPL v11
SPL
SPL Set ID 82562b68-224d-482a-b399-a89b81d5eb31
Route
ORAL
Published
Effective Date 2023-09-27
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Sirolimus (0.5 mg)
Inactive Ingredients
Alpha-tocopherol Acetate Cellulose, Microcrystalline Citric Acid Monohydrate Crospovidone (15 Mpa.s At 5%) Fd&c Yellow No. 5 Ferric Oxide Yellow Glyceryl Oleate Hypromelloses Lactose Monohydrate Poloxamer 188 Polyethylene Glycol, Unspecified Povidone Sucrose Talc Titanium Dioxide Crospovidone (120 .mu.m) Hypromellose 2910 (6 Mpa.s) Polyethylene Glycol 3350 Polyethylene Glycol 6000 Povidone K30 Ferric Oxide Red Polyethylene Glycol 8000

Identifiers & Packaging

Pill Appearance
Imprint: 21 Shape: round Color: yellow Color: white Size: 5 mm Size: 7 mm Size: 9 mm Score: 1
Marketing Status
ANDA Active Since 2023-02-16

Description

Sirolimus Tablets, 0.5 mg NDC 65841-771-01 100 Tablets Rx only Sirolimus Tablets, 1 mg NDC 65841-772-01 100 Tablets Rx only Sirolimus Tablets, 2 mg NDC 65841-773-01 100 Tablets Rx only


Medication Information

Description

Sirolimus Tablets, 0.5 mg NDC 65841-771-01 100 Tablets Rx only Sirolimus Tablets, 1 mg NDC 65841-772-01 100 Tablets Rx only Sirolimus Tablets, 2 mg NDC 65841-773-01 100 Tablets Rx only

Package Label.principal Display Panel

Sirolimus Tablets, 0.5 mg

NDC 65841-771-01

100 Tablets

Rx only

Sirolimus Tablets, 1 mg

NDC 65841-772-01

100 Tablets

Rx only

Sirolimus Tablets, 2 mg

NDC 65841-773-01

100 Tablets

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

Sirolimus Tablets, 0.5 mg

NDC 65841-771-01

100 Tablets

Rx only

Sirolimus Tablets, 1 mg

NDC 65841-772-01

100 Tablets

Rx only

Sirolimus Tablets, 2 mg

NDC 65841-773-01

100 Tablets

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)